A UUO-induced CKD mouse study suggested that EGCG exerts anti-inflammatory and antioxidative effects by inhibiting the NF-κB signaling pathway and activating the nuclear factor E2-related factor 2-Kelch-like ECH-associated protein 1 (Nrf2-Keap1) pathway [103]. The gene discussed is KEAP1; the disease is chronic kidney disease.